CB2 Insights (CSE:CBII) CEO Prad Sekar talked about taking the company public on the Canadian Securities Exchange with Zack Guzman and Yahoo Finance’s Sibile Marcellus and Charreah Jackson. CB2 Insights is an established, data-focused cannabis solution provider. The company’s mission is to mainstream medical cannabis into traditional healthcare by providing the industry with real-world evidence driven through its clinical operations.
In the interview, Sekar discussed how medications get introduced to the traditional medical healthcare system. Drug developers are required to provide evidence and information before it passes through “gatekeepers” to the market. If you don’t have the information that physicians and clinicians require or that information isn’t presented in a way that they’re used to, then your drug won’t go to market. As a result, CB2 Insights collects clinically-led, evidence-based data to help cannabis companies bring an advanced level of knowledge to the industry in terms of qualification, dosing and efficacy despite the lack of cannabis-based clinical trials. Sekar believes that this approach to medical cannabis can lead to its adoption into a more traditional healthcare setting.
CB2 Insights also run medical clinics that provide services and collect data from approximately 60,000 patients annually. To date, the company has generated C$10 million in revenue from its clinics. At the clinics, CB2 Insights collects data on the interactions between patients and physicians, which allows the company to standardize the information being looked at when treating patients, their outcomes and efficacy, Pekar explained. The clinics are addressing issues of patient-led, self-reported data, which can be difficult to validate. The clinics also act as a center of excellence for both patients and physicians.
To watch the full video, click here.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).